This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Su-Yon Kim: Innovator in Pharmaceutical Biotechnology
Introduction
Su-Yon Kim is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceutical biotechnology, particularly in the purification of erythropoietin analogs and the development of expression vectors for animal cells. With a total of 2 patents, his work is paving the way for advancements in drug production and therapeutic applications.
Latest Patents
One of Su-Yon Kim's latest patents is titled "Methods for purifying erythropoietin analogs having lower isoelectric point." This invention relates to a method for purifying an erythropoietin analog that has a low isoelectric point below 4. The method involves adding an N-linked sugar chain with high purity, allowing for effective purification through three-step chromatographic processes. This innovation not only reduces costs but also shortens the time required for purification.
Another significant patent is "Expression vector for animal cells including CSP-B 5'-SAR factor and method for producing recombinant proteins using same." This invention includes an expression vector for animal cells that comprises CSP-B 5'-SAR, a promoter operable in animal cells, and a polyadenylation sequence. The vector enhances the expression rate of target proteins, making it highly beneficial for the industrial mass production of drugs and antibodies.
Career Highlights
Su-Yon Kim is currently employed at Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the field of biotechnology. His work focuses on improving the efficiency and effectiveness of drug production processes, contributing to the advancement of medical treatments.
Collaborations
Some of his notable coworkers include Sang-Yong Lee and Yeo-Wook Koh, who collaborate with him on various projects within the pharmaceutical sector.
Conclusion
Su-Yon Kim's contributions to pharmaceutical biotechnology through his innovative patents are significant. His work not only enhances drug production processes but also holds promise for future advancements in medical therapies.